Technologies

Will Putin Prevent Rebrikov from Attempting Heritable Genome Editing?

By Pete Shanks | 10.08.2019

Biopolitical Times

The Russian molecular biologist who wants to edit the genomes of human embryos is getting impatient with authorities who won't yet let him go ahead.

Policies

U.S. Government Plans to Collect DNA from Detained Immigrants

By Caitlin Dickerson, The New York Times | 10.02.2019

Aggregated News

The Department of Homeland Security said it would begin collecting genetic data on hundreds of thousands of immigrants in federal detention facilities.

Genomics

Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon

By Emily Mullin, One Zero | 09.16.2019

Aggregated News

At least 10 babies have been born to apparently infertile women as a result of a controversial in vitro fertilization...

Assisted Reproduction

Illustrated color drawing the inside of a person's head, with the brain exposed. On the right side, there are social and creative activities in place. Grass surround this side of the brain. On the left side, people are working in cubicles.

Can CRISPR–Cas9 Boost Intelligence?

By Jim Kozubek, Scientific American | 09.23.2016

Aggregated News

Biopolitics

Landscape photo of an agricultural field. In the middle of the green field, there is a tractor.

Monsanto Licenses CRISPR Technology to Modify Crops — with Key Restrictions

By Sharon Begley, STAT | 09.22.2016

Aggregated News

Biopolitics

As Kuwait imposes world’s first DNA collection law, attorney tries to fight it

By Cyrus Farivar, ARS Technica | 09.22.2016

Aggregated News

Genomics

An embroidered set of chromosomes in rainbow colors are pictured close up.

Breaking Taboo, Swedish Scientist Seeks To Edit DNA Of Healthy Human Embryos

By Rob Stein, NPR [citing CGS' Marcy Darnovsky] | 09.22.2016

CGS-authored

Stem Cells

Illustrated clipboard, with three check marks on a generic list.

The End of China’s One-Child Policy Has Put Huge Pressure on the Nation’s Sperm Banks

By Hannah Beech, Time | 09.21.2016

Aggregated News

Bioethics

Titanic Clash Over CRISPR Patents Turns Ugly

By Heidi Ledford, Nature | 09.21.2016

Aggregated News

Global Governance

A public hearing is in session, angled as if the viewer was in the audience facing the representative officials.

Stem Cell Advocates and Critics Push Back on FDA Guidelines

By Alexandra Ossola, Scientific American | 09.21.2016

Aggregated News

Stem Cells

Patients Turn To San Diego Stem Cell Companies For Costly, Unproven Treatments

By David Wagner, KPBS | 09.20.2016

Aggregated News

Stem Cells